The Centers for Medicare & Medicaid Services has released two State Medicaid Director Letters clarifying new Medicaid requirements related to the Consolidated Appropriations Act enacted on December 27th, 2020.

SMD #21-005 (PDF), released on December 7th, covers new mandatory benefit for coverage of routine patient costs in connection with participation in qualifying clinical trials.

SMD #21-006 (PDF), released on December 10th, covers new requirements for state Medicaid programs, including new reporting requirements for non-Disproportionate Share Hospitals (DSH) supplemental payments, and a change in the methodology for calculating the hospital-specific DSH limit.